Other languages EHAVE, Inc.

Equities

EHVVF

CA28238M2058

Market Closed - OTC Markets Other stock markets 08:34:17 16/05/2024 pm IST			5-day change	1st Jan Change
0.001 ^USD	0.00%		0.00%	+233.33%

2023	Ei.Ventures, Inc. cancelled the acquisition of Mycotopia Therapies Inc. from EHAVE, Inc. (OTCPK:EHVV.F) and others in a reverse merger transaction.	CI
2022	FDA Grants EHAVE, Inc. Consent to Proceed with Its Clinical Study on Intravenous Ketamine Infusion for Major Depressive Disorder	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ei.Ventures, Inc. cancelled the acquisition of Mycotopia Therapies Inc. from EHAVE, Inc. (OTCPK:EHVV.F) and others in a reverse merger transaction.	16/23/16
FDA Grants EHAVE, Inc. Consent to Proceed with Its Clinical Study on Intravenous Ketamine Infusion for Major Depressive Disorder	15/22/15
EHAVE, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	28/22/28
EHAVE, Inc. Auditor Raises 'Going Concern' Doubt	27/22/27
EHAVE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	24/22/24
Ehave Announces Mycotopia Therapies Reaches Definitive Agreement on Triangular Merger with Ei.Ventures to Form PSLY.com to List on NASDAQ	23/22/23
Ehave, Inc. Announces MetaHealthU Will Enter The Market With A Focus On HPPD	19/22/19
Ehave, Inc. Continues Expansion Of KetaDASH Mobile Psychedelic Service By Providing Licensed Psychotherapists And Registered Nurses	03/22/03
EHAVE, Inc. (OTCPK:EHVV.F) completed the acquisition of Rejuv IV Inc.	09/22/09
Ehave, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	28/21/28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW